How Is Frontotemporal Dementia Different From Alzheimer's?

Alzheimer’s disease and frontotemporal dementia (FTD) are both progressive brain disorders, but they differ significantly in who they affect, how they typically begin, and what causes the damage in the brain. The most noticeable difference is their initial presentation: Alzheimer’s typically begins with memory loss in older adults, while FTD often begins with gradual changes in behavior, personality, or language in middle-aged adults. However, these are general patterns, not absolute rules, and it is important to remember that the behavioral changes in FTD are symptoms of a physical brain disease, not intentional choices or flaws in character.

Age of Onset

While dementia is often associated with the elderly, FTD follows a different timeline. FTD most often strikes people in their 50s or 60s, typically before the age of 65 ^[1][2]. Though it can occasionally happen earlier or later in life, FTD is one of the most common causes of dementia in people under 65. When FTD symptoms do appear after age 65, it is more commonly misdiagnosed as Alzheimer’s disease because of the patient’s older age ^[1][3]. In contrast, the vast majority of Alzheimer’s cases occur in people over age 65, and the risk increases significantly with advancing age.

Initial Symptoms (Patterns, Not Rules)

The earliest signs of these two diseases are generally distinct, reflecting the different areas of the brain they target first.

• Alzheimer’s Disease: The hallmark early symptom is progressive loss of episodic memory (the ability to remember recent events and personal experiences) ^[4]. People with typical Alzheimer’s often struggle to recall recent conversations or frequently misplace items.
• Frontotemporal Dementia: Memory is generally preserved in the early stages of typical FTD, though memory issues can occasionally occur. Instead, families first notice profound shifts in the person’s behavior or communication skills. In the behavioral variant of FTD (bvFTD), early symptoms include apathy (loss of motivation), a loss of empathy, inappropriate social behavior, compulsive actions, and dietary changes, such as intensely craving sweets ^[2][5][6].
• Language Symptoms (PPA): Primary Progressive Aphasia (PPA) is a clinical syndrome where language declines first. The “semantic” and “nonfluent” variants of PPA involve struggling to understand words or speak fluidly and are usually caused by FTD pathology ^[7][8]. However, a third variant called “logopenic” PPA, where people struggle to find the right words in conversation, is actually most often associated with Alzheimer’s disease pathology ^[9].

Changes in the Brain (Proteins and Pathology)

Both diseases involve the abnormal buildup of proteins in the brain, but the specific culprit proteins are different.

• Alzheimer’s Proteins: Alzheimer’s disease is defined by two specific protein abnormalities: amyloid plaques (clumps of beta-amyloid protein outside the cells) and neurofibrillary tangles (twisted strands of tau protein inside the cells) ^[10][11].
• FTD Proteins: The clinical syndrome of FTD is caused by underlying brain changes known as frontotemporal lobar degeneration (FTLD). FTLD typically does not involve amyloid plaques. Instead, it is most commonly driven by abnormal accumulations of either Tau protein or TDP-43 protein, and rarely a protein called FUS ^[12][13][14].

It is currently very difficult for clinicians to determine the exact protein subtype (Tau vs. TDP-43) during life using standard clinical tests; definitive classification often requires examination of brain tissue after passing, though genetic testing or research scans can sometimes provide clues ^[12]. Furthermore, overlaps are common. Older individuals may have multiple types of protein buildup happening simultaneously ^[15].

How Clinicians Use Brain Scans

Because FTD and Alzheimer’s affect different parts of the brain, doctors use neuroimaging as supportive tools. Scans are not definitive standalone answers and must be interpreted alongside a patient’s medical history and cognitive testing ^[16].

• MRI Scans: An MRI looks at the physical structure of the brain. In FTD, the shrinkage (atrophy) is typically early and most prominent in the frontal lobes (behind the forehead) and anterior temporal lobes (behind the ears) ^[17][18]. In Alzheimer’s, the shrinkage usually starts in the medial temporal regions, including the hippocampus (a deep brain structure vital for memory), and the temporoparietal areas towards the back of the brain ^[17].
• FDG-PET Scans: A functional scan called an FDG-PET measures how the brain uses sugar for energy. FTD usually shows decreased energy use (hypometabolism) in the frontal and anterior temporal regions, whereas Alzheimer’s shows reduced energy use in the parietotemporal and posterior areas ^[19][20].
• Amyloid PET and Lumbar Punctures: Doctors may use an amyloid PET scan or a lumbar puncture (spinal tap) to help assess whether Alzheimer’s-type amyloid pathology is present. A negative result makes Alzheimer’s much less likely. However, a positive amyloid scan only establishes that amyloid is present—it does not by itself prove that Alzheimer’s is the sole cause of the person’s symptoms, as older individuals can have age-related amyloid buildup alongside FTD ^[21][22].

What This Distinction Means for Care

Knowing the difference between FTD and Alzheimer’s is critical for planning care. Standard Alzheimer’s medications (like donepezil) do not improve FTD symptoms and can sometimes worsen behavioral issues, so they should not be started or stopped without consulting the treating clinician. Instead, FTD care focuses on targeted symptom management, behavioral adaptations, speech-language therapy for communication difficulties, and robust support systems to help caregivers navigate the unique emotional and practical challenges of the disease.

(Note: Sudden or rapidly evolving changes in behavior, memory, or language are not typical of slowly progressive dementias like FTD or Alzheimer’s, and warrant prompt emergency medical evaluation for other causes.)